Design and Synthesis of Phosphonoacetic Acid (PPA) Ester and Amide Bioisosters of Ribofuranosylnucleoside Diphosphates as Potential Ribonucleotide Reductase Inhibitors and Evaluation of Their Enzyme Inhibitory,Cytostatic and Antiviral Activity
Free accessResearch articleFirst published online August, 2003
Design and Synthesis of Phosphonoacetic Acid (PPA) Ester and Amide Bioisosters of Ribofuranosylnucleoside Diphosphates as Potential Ribonucleotide Reductase Inhibitors and Evaluation of Their Enzyme Inhibitory,Cytostatic and Antiviral Activity
Continuing our investigations on inhibitors of ribonucleotide reductase (RNR), the crucial enzyme that catalyses the reduction of ribonu-cleotides to deoxyribonucleotides, we have now prepared and evaluated 5′-phosphonoacetic acid, amide and ester analogues of adenosine, uridine and cytidine with the aim to verify both substrate specificity and contribution to biological activity of diphosphate mimic moieties. A molecular modelling study has been conducted on the RNR R1 subunit, in order to verify the possible interaction of the proposed bioisosteric moieties. The study compounds were finally tested on the recombinant murine RNR showing a degree of inhibition that ranged from 350 μM for the UDP analogue 5′-deoxy-5′-N-(phosphon-acetyl)uridine sodium salt (amide) to 600 μM for the CDP analogue 5′-O-[(diethyl-phosphon)acetyl]cytidine (ester). None of the tested compounds displayed noteworthy cytostatic activity at 100–500 μM concentrations, whereas ADP analogue 5′-N-[(diethyl-phosphon) acetyl]adenosine (amide) and 5′-deoxy-5′-N-(phos-phon-acetyl)adenosine sodium salt (amide) showed a moderate inhibitory activity (EC50: 48 μM) against HSV-2 and a modest inhibitory activity (EC50: 110 μM) against HIV-1, respectively.
BallatoreCMcGuiganCDe ClercqEBalzariniJ (2001) Synthesis and evaluation of novel amidate prodrugs of PMEA and PMPA. Bioorganic and Medicinal Chemistry Letters11: 1053–1056.
2.
BalzariniJ (1993) Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives. Pharmacy World Science16: 113–126.
3.
BazzaniniRManfrediniSDuriniEGroschelBCinatlJBalzariniJDe ClercqEImbachJLPerigaudCGosselinG (1999) Synthesis, cytostatic activity and inhibition of ribonucleotide reductase by 5′-phosphoramidates and 5′- diphosphate, of 2′-O-allylarabinofuranosyl nucleosides. Nucleosides & Nucleotides18: 971–972.
4.
BoehmerPELehmanIR (1997) Herpes simplex virus DNA replication. Annual Review of Biochemistry66: 347–84.
5.
CaseDAPearlmanDACaldwellJWCheathamTEIIIRossWSSimmerlingCLDardenTAMerzKMStantonRVChengALVincentJJCrowleyMTsuiVRadmerRJDuanYPiteraJMassovaISeibelGLSinghUCWeinerPKKollmanPA (1999) AMBER 6. University of California: San Francisco, USA.
6.
CharvetASCamploMFauryPGracietJCMourierNChermannJCKrausJL (1994) Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate- and phos-phonoacetate-2′,3′-dideoxy-3′-thiacytidine conjugates. Journal of Medicinal Chemistry37: 2216–2223.
7.
CharvetASTurinFFauryPHantzOCamploMMourierNBerthillonPGracietJCChermannJCTrepoCKrausJ-L (1994) Synthesis and antiviral activity of new carbonylphosphonate 2′,3′-dideoxy-3′-thiacytidine conjugates. Antiviral Research25: 161–168.
8.
CornellWDCieplakPBaylyCIGouldIRMerzKMJr.FergusonDMSpellmeyerDCFoxTCaldwellJWKollmanPA (1995) A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. Journal of American Chemical Society117: 5179–5197.
9.
EngströmYErikssonSThelanderLÅkermanM (1979) Ribonucleotide reductase from calf thymus. Purification and properties. Biochemistry14: 2941–2948.
10.
ErikssonMUhlinURamaswamySEkbergMRegnströmKSjöbergBMEklundH (1997) Binding of allosteric effectors to ribonucleotide reductase protein R1: Reduction of active-site cys-teines promotes substrate binding. Structure5: 1077–1092.
11.
GriffeyRHPoulterCD (1983) Detection of the imino hydrogen bond in G-C pairs by H and N nuclear magnetic resonance spectroscopy. Tetrahedron Letters24: 4067–4070.
12.
HamptonA (1961) A new procedure for the conversion of ribonucleosides to 2′,3′-O-isopropilidene derivates. Journal of the American Chemical Society83: 3640–3645.
13.
HeinemanTCCohenJI (1994) Deletion of the varicella-zoster virus large subunit of ribonucleotide reductase impairs growth of virus in vitro. Journal of Virology68: 3317–3323.
14.
JayaramBSprousDBeveridgeDL (1998) Solvation free energy of biomacromolecules: Parameters for a modified generalized Born model consistent with the AMBER force field. Journal of Physical Chemistry B102: 9571–9576.
15.
JohanssonNGErikssonS (1996) Structure-activity relationships for phosphorylation of nucleoside analogs to monophosphates by nucleoside kinases. Review. Acta Biochimica Polonica43: 143–160.
16.
KudlacekOMitterauerTNanoffCHoheneggerMTangWJFreissmuthMKleussC (2001) Inhibition of adenylyl and guanylyl cyclase isoforms by the antiviral drug foscarnet. Journal of Biological Chemistry276: 3010–3016.
17.
KukhanovaMKrayevskyAPrrusoffWChengYC (2000) Design of anti-HIV compounds: From nucleoside to nucleoside 5′-triphosphate analogs. Problems and perspectives. Review. Current Pharmaceutical Design6: 585–598.
18.
LambertRWMartinJAThomasGJDuncanIBHallMJHeimerEP (1989) Synthesis and antiviral activity of phospho-noacetic and phosphonoformic acid esters of 5-bromo-2′-deoxyuri-dine and related pyrimidine nucleosides and acyclonucleosides. Journal of Medicinal Chemistry32: 367–374.
19.
MacChiaMMartinelliAParkinARosselloA (1994) Bioisosters of the diphosphate group in activated forms of antiherpes virus agents. A theoretical study. Farmaco49: 325–332.
20.
MacCossMRyuEKWhiteSRLastLR (1980) A new synthetic use of nuleoside N1-oxides. Journal of Organic Chemistry45: 788–794.
21.
ManfrediniSBaraldiPGBazzaniniRSimoniDVertuaniSPaniAScintuFPinnaELichinoDLa CollaP (1996) Pyrazole related nucleosides. Design, synthesis and antiproliferative activity of methyl-4-iodo-1-β-D-ribofuranosyl-pyrazole-3-carboxylate (IPCAR) and derivatives against human leukemias, lymphomas and solid tumors cell in vitro. Medicinal Chemistry Research6: 93–311.
22.
ManfrediniSBazzaniniRMarangoniMBaraldiPGSimoniDVertuaniSPaniAScintuFPinnaELichinoDLa CollaP (1996) Design, synthesis and antiproliferative activity of methyl-4-iodo-1-β-D-ribofuranosyl-pyrazole-3-carboxylate and related compounds. Bioorganic & Medicinal Chemistry Letters11: 1279–1284.
23.
ManfrediniSBaraldiPGDuriniEBalzariniJDe ClercqEKarlssonABuzzoniVThelanderL (1999) Synthesis, cytostatic activity and inhibition of ribonucleotide reductase by 5′-phospho-ramidates and 5′- diphosphate, of 2′-O-allylarabinofuranosyl nucleosides. Nucleosides & Nucleotides18(4–5): 1007–1008.
24.
ManfrediniSBaraldiPGDuriniEVertuaniSBalzariniJDe ClercqEKarlssonABuzzoniVThelanderL (1999) 5′-Phosphoramidates and 5′-Diphosphates of 2′-O-Allyl-D-arabino-furanosyl- uracil, -cytosine, and -adenine: Inhibition of ribonucleotide reductase. Journal of Medicinal Chemistry42: 3243–3250.
25.
ManfrediniSLamprontiIVertuaniSSolaroliNRecanatiniMBryanDMcKinneyM (2000) Design, synthesis and binding at cloned muscarinic receptors of N-[5-(1′-substituted-ace-toxymethyl)-3-oxadiazolyl] and N-[4-(1′-substituted-ace-toxymethyl)-2-dioxolanyl] dialkyl amines. Bioorganic and Medicinal Chemistry8: 1559–1566.
26.
MannGJGräslundAOchiaiEIIngemarsonRThelanderL (1991) Purification and characterization of recombinant mouse and Herpes Simplex Virus ribonucleotide reductase R2 subunit. Biochemistry30: 1939–1947.
27.
MeierC (1998) Pro-nucleotides. Recent advances in the design of efficient tools for the delivery of biologically active nucleoside monophosphates. Synthesis Letters233–242.
28.
PearlmanDACaseDACaldwellJWRossWSCheathamTEIIIDeBoltSFergusonDSeibelGLKollmanPA (1995) AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules. Computer Physics Communications91: 1–41.
29.
PlunkettWHuangPSearcyCEGandhiV (1996) Gemcitabine: Preclinical pharmacology and mechanisms of action. Review. Seminars in Oncology5: 3–15.
30.
ThelanderMMannGJBehravanGSoucyFBeaulieuPLavalléePGräslundAThelanderL (1994) Purification, characterization and localization of subunit interaction area of recombinant mouse ribonucleotide reductase R1 subunit. Journal of Biological Chemistry269: 23171–23176.
31.
WagnerCRIyerVVMcIntezEJ (2000) Pronucleotides: Toward the in vivo delivery of antiviral and anti-cancer nucleotides. Medicinal Research Reviews20: 417–451.
32.
WeiserJShenkinPSStillWC (1999) Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO). Journal of Comparative Chemistry20: 217–230.
